ARO-PNPLA3

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameARO-PNPLA3
Drug Alias NameARO-JNJ1ARO JNJ1ARO-PNPLA-3ARO-PNPLA3JNJ-0795 +[6] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 inhibitors
Targets1-acylglycerol-3-phosphate O-acyltransferase PNPLA3
Therapy Area/IndicationsFatty LiverLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development LlcMadrigal Pharmaceuticals Inc
Inactive CompaniesJanssen Pharmaceutical Kk
Active IndicationsLiver Diseases
Inactive IndicationsFatty Liver

Other Information

ATC CodeN/A
Related LinksN/A